Literature DB >> 21257598

Acquired antimicrobial resistance in equine Rhodococcus equi isolates.

F Boyen1, F Pasmans, F Haesebrouck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257598     DOI: 10.1136/vr.c5289

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  4 in total

1.  The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Authors:  Margot Schlusselhuber; Riccardo Torelli; Cecilia Martini; Matthias Leippe; Vincent Cattoir; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Maurizio Sanguinetti; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

2.  In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Authors:  Margot Schlusselhuber; Sascha Jung; Oliver Bruhn; Didier Goux; Matthias Leippe; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

3.  Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Steeve Giguère; Elisa Anastasi; Jack Hearn; Mariela Scortti; José A Vázquez-Boland
Journal:  mBio       Date:  2019-10-15       Impact factor: 7.867

4.  Minimum inhibitory concentrations of erythromycin and rifampin for Rhodococcus equi during the years 2007-2014.

Authors:  Caitriona S Fenton; Thomas C Buckley
Journal:  Ir Vet J       Date:  2015-10-06       Impact factor: 2.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.